Clinical Trials Directory

Trials / Completed

CompletedNCT02515370

Friends for Life Circles for Option B Plus

Using Enhanced Peer Group Strategies to Support Prevention of Mother to Child HIV Transmission (PMTCT) Option B+ in Uganda

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
540 (actual)
Sponsor
MU-JHU CARE · Academic / Other
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The main goal of the study is to support HIV-infected pregnant women initiated on PMTCT Option B+ during antenatal to adhere to lifelong ART and postpartum care visits through an enhanced group peer support intervention called "friends for life circles".

Detailed description

The overall goal of this implementation research is to improve retention in care and adherence to ART to 2 years postpartum among HIV infected women in urban and rural Uganda choosing PMTCT Option B+. Formative research will first be conducted to assess knowledge and attitudes regarding Option B+ and lifelong ART among PMTCT clients, community members and health workers. The formative research will inform the design of the group peer support intervention. Interventional research will then be conducted randomizing 540 women to either enhanced group peer support with income generating activities called the Friends for Life Circle (FLC) or MOH standard of care counselling with follow-up to 2 years postpartum. Primary outcomes will include retention in health care, ARV adherence and viral suppression at 6 weeks and 24 months postpartum. Secondary outcomes will include participants' health and economic outcomes.

Conditions

Interventions

TypeNameDescription
OTHERFriends for Life Circles (FLCs).The intervention 'Friends for Life Circles" (FLCs) will build dynamic peer group support in the community aimed at supporting maternal adherence to appointment keeping and taking lifetime antiretroviral drugs

Timeline

Start date
2016-05-01
Primary completion
2019-05-01
Completion
2020-08-01
First posted
2015-08-04
Last updated
2023-03-17

Locations

1 site across 1 country: Uganda

Source: ClinicalTrials.gov record NCT02515370. Inclusion in this directory is not an endorsement.